The nurse teaches a client with chronic pancreatitis how to monitor the effectiveness of pancreatic enzyme replacement therapy. Which instruction should the nurse include?

Rationale: A. Tracking fluid intake is generally part of maintaining overall hydration and managing general health, but it does not provide information about how well pancreatic enzymes are working. Pancreatic enzyme replacement therapy (PERT) is aimed at improving digestion, particularly fat absorption, rather than influencing fluid balance. Therefore, while hydration is important, it is not an indicator of therapy effectiveness. B. The main purpose of PERT is to replace digestive enzymes that the pancreas is no longer producing adequately, particularly lipase, amylase, and protease, to aid in digestion of fats, carbohydrates, and proteins. Steatorrhea—characterized by bulky, oily, pale, or foul-smelling stools—is a direct sign of fat malabsorption. By observing changes in stool consistency, color, and frequency, the client can assess whether the enzyme therapy is effectively aiding digestion. A decrease in steatorrhea indicates the therapy is working, while persistent fatty stools suggest the need for dosage adjustment or adherence review. C. Urine ketone testing is used primarily for clients at risk for diabetic ketoacidosis or during prolonged fasting/starvation. It reflects fat breakdown for energy due to insufficient insulin, not fat malabsorption. Therefore, it is unrelated to assessing the effectiveness of pancreatic enzymes in chronic pancreatitis. D. Clients with chronic pancreatitis may develop diabetes mellitus due to pancreatic damage, making glucose monitoring important for glycemic control. However, glucose levels do not indicate whether pancreatic enzyme therapy is effectively digesting fats, proteins, and carbohydrates. Monitoring stool characteristics remains the most direct and clinically relevant measure.